Were you perhaps unduly skeptical of ABT’s HCV claims back in October? ABT does not have a habit of boasting unduly and we’re not talking about a small biotech company who needs to generate hype in order to raise capital on favorable terms. Regards, Dew
p.s. ABT is trading at an all-time today.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”